VA Tennessee Valley, Health Care System

Nashville, Tennessee 37232

1 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases, Chronic Kidney Disease (CKD) Stage 5, Chronic Kidney Disease, Stage 5, Chronic Myelogenous Leukemia (CML), Chronic Pain, Coronary Heart Disease, Disorders of the Immune System, Heart Failure, Heart Failure With Preserved Ejection Fraction (HFpEF), Hematologic Malignancies

Studies at this site

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• Endogenous Opioid Response to Injections — Recruiting now
• Tele-Collaborative Outreach to Rural Patients With Chronic Pain — Running, not enrolling
• DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers — Running, not enrolling
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
• Head to Head Study Against Sevelamer Hydrochloride — Completed
• Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) — Completed
• INcrease Of VAgal TonE in CHF — Stopped early
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 — Stopped early
• Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease — Status unconfirmed